135 related articles for article (PubMed ID: 35280729)
1. Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants.
Freire MV; Martin M; Thissen R; Van Marcke C; Segers K; Sépulchre E; Leroi N; Lété C; Fasquelle C; Radermacher J; Gokburun Y; Collignon J; Sacré A; Josse C; Palmeira L; Bours V
Front Oncol; 2022; 12():835581. PubMed ID: 35280729
[TBL] [Abstract][Full Text] [Related]
2. Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family.
Chan JM; Clendenning M; Joseland S; Georgeson P; Mahmood K; Joo JE; Walker R; Como J; Preston S; Chai SM; Chu YL; Meyers AL; Pope BJ; Duggan D; Fink JL; Macrae FA; Rosty C; Winship IM; Jenkins MA; Buchanan DD
Fam Cancer; 2024 Mar; 23(1):9-21. PubMed ID: 38063999
[TBL] [Abstract][Full Text] [Related]
3. Endometrial Cancers in
Smith ES; Da Cruz Paula A; Cadoo KA; Abu-Rustum NR; Pei X; Brown DN; Ferrando L; Sebastiao APM; Riaz N; Robson ME; Soslow RA; Reis-Filho JS; Mandelker D; Weigelt B
JCO Precis Oncol; 2019; 3():. PubMed ID: 32914019
[TBL] [Abstract][Full Text] [Related]
4. Homologous Recombination Abnormalities Associated With
Albitar M; Zhang H; Pecora A; Waintraub S; Graham D; Hellmann M; McNamara D; Charifa A; De Dios I; Ma W; Goy A
Breast Cancer (Auckl); 2023; 17():11782234231198979. PubMed ID: 37789896
[TBL] [Abstract][Full Text] [Related]
5. Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes.
Timms KM; Abkevich V; Hughes E; Neff C; Reid J; Morris B; Kalva S; Potter J; Tran TV; Chen J; Iliev D; Sangale Z; Tikishvili E; Perry M; Zharkikh A; Gutin A; Lanchbury JS
Breast Cancer Res; 2014 Dec; 16(6):475. PubMed ID: 25475740
[TBL] [Abstract][Full Text] [Related]
6. Tumor Testing for Somatic and Germline
Peixoto A; Pinto P; Guerra J; Pinheiro M; Santos C; Pinto C; Santos R; Escudeiro C; Bartosch C; Canário R; Barbosa A; Gouveia A; Petiz A; Abreu MH; Sousa S; Pereira D; Silva J; Teixeira MR
Front Oncol; 2020; 10():1318. PubMed ID: 32850417
[TBL] [Abstract][Full Text] [Related]
7. Functional
Meijer TG; Verkaik NS; Sieuwerts AM; van Riet J; Naipal KAT; van Deurzen CHM; den Bakker MA; Sleddens HFBM; Dubbink HJ; den Toom TD; Dinjens WNM; Lips E; Nederlof PM; Smid M; van de Werken HJG; Kanaar R; Martens JWM; Jager A; van Gent DC
Clin Cancer Res; 2018 Dec; 24(24):6277-6287. PubMed ID: 30139880
[TBL] [Abstract][Full Text] [Related]
8. Homologous recombination deficiency (HRD) status predicts response to standard neoadjuvant chemotherapy in patients with triple-negative or BRCA1/2 mutation-associated breast cancer.
Telli ML; Hellyer J; Audeh W; Jensen KC; Bose S; Timms KM; Gutin A; Abkevich V; Peterson RN; Neff C; Hughes E; Sangale Z; Jones J; Hartman AR; Chang PJ; Vinayak S; Wenstrup R; Ford JM
Breast Cancer Res Treat; 2018 Apr; 168(3):625-630. PubMed ID: 29275435
[TBL] [Abstract][Full Text] [Related]
9. Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer.
Patel JN; Braicu I; Timms KM; Solimeno C; Tshiaba P; Reid J; Lanchbury JS; Darb-Esfahani S; Ganapathi MK; Sehouli J; Ganapathi RN
Br J Cancer; 2018 Oct; 119(9):1060-1066. PubMed ID: 30318511
[TBL] [Abstract][Full Text] [Related]
10. Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer.
Kraya AA; Maxwell KN; Wubbenhorst B; Wenz BM; Pluta J; Rech AJ; Dorfman LM; Lunceford N; Barrett A; Mitra N; Morrissette JJD; Feldman M; Nayak A; Domchek SM; Vonderheide RH; Nathanson KL
Clin Cancer Res; 2019 Jul; 25(14):4363-4374. PubMed ID: 30914433
[TBL] [Abstract][Full Text] [Related]
11. Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer.
Mutter RW; Riaz N; Ng CK; Delsite R; Piscuoglio S; Edelweiss M; Martelotto LG; Sakr RA; King TA; Giri DD; Drobnjak M; Brogi E; Bindra R; Bernheim G; Lim RS; Blecua P; Desrichard A; Higginson D; Towers R; Jiang R; Lee W; Weigelt B; Reis-Filho JS; Powell SN
J Pathol; 2017 Jun; 242(2):165-177. PubMed ID: 28299801
[TBL] [Abstract][Full Text] [Related]
12. Homologous Recombination Deficiency Scar: Mutations and Beyond-Implications for Precision Oncology.
van der Wiel AMA; Schuitmaker L; Cong Y; Theys J; Van Hoeck A; Vens C; Lambin P; Yaromina A; Dubois LJ
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077694
[TBL] [Abstract][Full Text] [Related]
13. Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration.
Tsang ES; Csizmok V; Williamson LM; Pleasance E; Topham JT; Karasinska JM; Titmuss E; Schrader I; Yip S; Tessier-Cloutier B; Mungall K; Ng T; Sun S; Lim HJ; Loree JM; Laskin J; Marra MA; Jones SJM; Schaeffer DF; Renouf DJ
NPJ Precis Oncol; 2023 Mar; 7(1):31. PubMed ID: 36964191
[TBL] [Abstract][Full Text] [Related]
14. Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer.
von Wahlde MK; Timms KM; Chagpar A; Wali VB; Jiang T; Bossuyt V; Saglam O; Reid J; Gutin A; Neff C; Lanchbury JS; Hatzis C; Hofstatter E; Pusztai L
Clin Cancer Res; 2017 Mar; 23(5):1193-1199. PubMed ID: 27601588
[No Abstract] [Full Text] [Related]
15. A de novo germline pathogenic BRCA1 variant identified following an osteosarcoma pangenomic molecular analysis.
Mouren A; Chansavang A; Hamzaoui N; Srikaran A; Laurent-Puig P; Marisa L; De Percin S; Lupo A; Larousserie F; Blons H; L'Haridon A; Burnichon N; Pasmant E; Tlemsani C
Fam Cancer; 2024 May; ():. PubMed ID: 38763984
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of homologous recombination-deficient breast cancers with special reference to response to neoadjuvant paclitaxel followed by FEC.
Imanishi S; Naoi Y; Shimazu K; Shimoda M; Kagara N; Tanei T; Miyake T; Kim SJ; Noguchi S
Breast Cancer Res Treat; 2019 Apr; 174(3):627-637. PubMed ID: 30607631
[TBL] [Abstract][Full Text] [Related]
17. A subset of lung cancer cases shows robust signs of homologous recombination deficiency associated genomic mutational signatures.
Diossy M; Sztupinszki Z; Borcsok J; Krzystanek M; Tisza V; Spisak S; Rusz O; Timar J; Csabai I; Fillinger J; Moldvay J; Pedersen AG; Szuts D; Szallasi Z
NPJ Precis Oncol; 2021 Jun; 5(1):55. PubMed ID: 34145376
[TBL] [Abstract][Full Text] [Related]
18. Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer.
How JA; Jazaeri AA; Fellman B; Daniels MS; Penn S; Solimeno C; Yuan Y; Schmeler K; Lanchbury JS; Timms K; Lu KH; Yates MS
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33668244
[TBL] [Abstract][Full Text] [Related]
19. Homologous Recombination Repair Mechanisms in Serous Endometrial Cancer.
Jönsson JM; Bååth M; Björnheden I; Sahin ID; Måsbäck A; Hedenfalk I
Cancers (Basel); 2021 Jan; 13(2):. PubMed ID: 33445465
[TBL] [Abstract][Full Text] [Related]
20. Signatures associated with homologous recombination deficiency and immune regulation to improve clinical outcomes in patients with lung adenocarcinoma.
Shang X; Qi K; Liu X; Liu Q; Zhang X; Wang D; Huang W
Front Oncol; 2022; 12():854999. PubMed ID: 36249053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
